QuickView for Arginyl-tRNA synthetase, catalytic core domain (biogroup)

1. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
2. L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
3. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
4. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
5. Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]

There were no matches for Arginyl-tRNA synthetase, catalytic core domain

There were no clinical trials for Arginyl-tRNA synthetase, catalytic core domain